Over the past several weeks I have been scanning the going private deal of Emmis Communications Corp (EMMS). EMMS is a media conglomerate owning mostly radio stations and some magazines throughout the U.S. and in some Eastern European countries. The going private deal is being led by Jeffrey Smulyan, the founder and CEO of Emmis, and financed by Alden Capital. No new updates have come out since the shares began tendering on June 2nd, and I don’t foresee any news coming out till the tender offer period ends at Midnight June 29th.
So…with a 7% premium and one week to close, I figured this would be a good time to talk about this deal.
The Workout Checklist
This deal seemed pretty straight forward through most of the steps to decide if this was a workout:
- Due diligence by both parties;
- Agree on a price, terms, and contingencies (financing, regulator approval);
- Get preliminary shareholder sentiment (or controlling shareholder approval);
- Secure financing arrangements (if needed);
- Obtain regulator (SEC, FCC, any and all) approval;
- Get final shareholder approval at a meeting called for that purpose;
- Complete the deal.
The first three steps are usually a given if you are looking at a deal that has been around for a while with no roadblocks. In this case, these steps had been completed.
The Financing
Financing from Alden Capital had been secured, and they had a hand in the way things had been and were going to play out.
Mr. Smulyan is an all-star in the industry and has some political ties as he has represented the U.S. in International telecommunications conferences. In this going private transaction, there is little fear of regulatory disapproval due to it being a buyout by Smulyan and there being no real antitrust issues. I suppose there is a slight possibility of some FCC regulatory approval issues, but regulatory approval from any government body is not an issue I am worried about.
The Problem
Obtaining final shareholder approval is the step that I am hung up on, and I can’t decide if this is a low-risk workout or not. The stock of the company is split up into several different classes and approval of this deal is reliant on two separate votes. The first class of votes is guaranteed due to the fact that Smulyan has majority voting rights with all of the common stock votes and a simple majority of votes is needed to make the deal go through.
The second class of shares that needs to vote for approval is that of the of 6.25% Series A Preferred Stock. In order for this deal to go through, 2/3 of the preferred shares need to vote for certain provisions to be amended and for the deal to go through. Alden currently holds 41.4% of the preferred stock and will vote in favor for the transaction to go through. That means another 25.2% of all preferred shares outstanding needs to vote in favor of the transaction or 43% of the remaining 58.6% of votes not attributable to Alden.
Scratching My Head
The problem with this is it’s not certain if preferred shareholders will agree to what they’re getting out of the deal. Currently, dividends have not been paid since October 15, 2008 for a total of $11.3 million dollars in arrears. They will either be converted into 2.44 shares for $5.856 in cash or will be converted into 12% PIK Senior Subordinated Notes due 2017 at a rate of $30.00 principal amount of New Notes for each $50.00 liquidation preference of Existing Preferred Stock. Dividends in arrears would not be paid and would be wiped out.
Since so many more shares are necessary for approval besides those of Alden, it is not certain if this deal will go through and so far I have shied away from investing in it. Have you looked at this one? Any thoughts?
Filed under: Workouts, Arbitrage, & Hedges
Related Stocks: EMMS
Thanks DrSues. As you noted in your article the deal price is at a substantial premium to the 30 day and 180 day average price, a premium of 74% and 118% respectively. Not sure that the long term prospects for this industry look to good so many shareholders are probably going to take what they can get.
( REPLY )
News released today. Preliminary proxy statement is released as well as news that the tender offer deadline is being extended by one day. There is also some information about changes in the financing of the deal. I saw a bit potentially negative to the deal in one of the news articles that says approximately 193,943 shares of Class A Common Stock have been tendered where there are about 32 million shares outstanding. I am going to be digging through this and hopefully we can share some conclusions at the end of the day.
( REPLY )
A couple odd but not unexpected turn of events have taken place. The tender offer has been extended to the end of July instead of the end of June and provisions have been made that do not require Alden to provide the financing. I’m beginning to have some doubts as to the probability of this deal going through due to recent problems and the few shares that have been tendered for class A common stock (even thought they aren’t necessary) leaves me with some doubt as to the the probability of enough preferred shares voting yes for the deal.
( REPLY )
Looking at the stakeholders, the lack of opposition and the due diligence, I would have to agree that the likelihood of this deal going through is very high.
But quick question.
Why wait for the merger to end? Couldnt you just purchase a truckload of shares at current prices and tender the shares before july 30 for the full $2.40?
( REPLY )
Argh! Morningstar is started to migrate their financial data that the spreadsheet usually reference (the “quicktake” pages). The first to go has been the income statement page, and now I can’t pull that data from the website.
Can anyone let me know if they’ve found another way (beside manually) to pull the financial data so that I can continue to use my spreadsheets to estimate intrinsic value just by putting in the stock ticker?
( REPLY )



Joseph,
Nice analysis. As you mentioned, the common stock vote is already assured since Smulyan owns a majority. With Alden on-board on the preferred side, I think the chances of the merger not getting approved are relatively slim.
See my take here: http://www.valueuncovered.com/emms-going-private-transaction
( REPLY )